Medical Information

3.31.2014 Medical Affairs

Looking Outside the Box: How Medical Communications Groups Engage the Medical Community

By Victoria Cavicchi, Research Analyst As the life sciences industry grows, companies’ internal groups must also evolve to match changing demands.  One surveyed pharmaceutical executive explained, “By and large, companies seem to know that...
 

3.28.2014 Medical Affairs

On the Lookout: Pharmaceutical Call Center Outsourcing, Performance Measurement and More!

By Christie Shilling, Research Analyst Medical information teams serve not only as the central hub to which other functions can turn for scientific knowledge, but also as the primary contact center from which HCPs, pharmacists and patients can all...
 

2.19.2014 Medical Affairs

Advisory Boards Put the Marketplace in Your Conference Room

By Jacob Presson, Research Analyst This blog has previously discussed in detail how pharmaceutical companies are turning to advisory boards to inform their clinical trial strategies and increasingly to provide assistance when conferring with payers...
 

11.18.2013 Medical Affairs

Tips for Medical Affairs Teams Fighting to Eradicate Communicable Diseases

By Jennifer Harrell, Research Analyst While ideological debates and bitter feuds over healthcare reform rage on in America, developing countries suffer from the crippling effects of neglected tropical diseases. Trachoma, for example, is an eye disease...
 

9.24.2013 Medical Affairs

Great Moderators Key to Pharmaceutical Advisory Board Success

By Jacob Presson, Research Analyst Pharmaceutical companies are evolving their advisory board strategies to keep pace with the rapid changes that the entire industry is experiencing. As payer demands increase in complexity, the importance of engaging...
 

5.1.2013 Medical Affairs

Product Launch: A Busy Time for Medical Affairs Teams

Marketing and commercial teams get a lot of the credit for a successful product launch, but medical affairs teams are typically buzzing with activity in the months (sometimes even years) preceding drug approval.  As the official communication channel between a...
 

4.8.2013 Medical Affairs

Product Development Stage Dictates Medical Affairs Spending Patterns

Although marketing and market access functions may not support a developing drug until Phase 2 or even later, companies need to coordinate between several different teams as products move through different development stages beginning in the pre-clinical stage....
 

4.4.2013 Medical Affairs

Technology’s Role in Enhancing and Expanding Medical Information Teams’ Capabilities

Within companies’ medical affairs groups, medical information subfunctions disseminate information quickly across consumer and healthcare practitioner audiences alike.  However, US companies rely on different-sized medical information teams to fulfill these...
 

6.20.2012 Medical Affairs

Medical Information Teams Often Double as Corporate Library

By Ryan McGuire, Senior Research Analyst As their name suggests, medical information teams are charged with organizing and understanding pharmaceutical companies’ referenced clinical literature. These teams’ handling of companies’ medical literature...
 

12.21.2011 Medical Affairs

Country-Level Medical Affairs Budgets Now Average Almost $2 Million

Country-level medical affairs budgets currently average $1.9 million across Asia, Europe, North America and South America, according to our recent benchmarking study, with pharmaceutical and biotech companies boosting their investment in medical affairs affiliates...